Conference on Oncology and Immunoherapy: Last Information - conf.ltr [1/1]

Evgeny S.Pobegalov thorax at infopro.spb.su
Fri Sep 6 20:27:32 EST 1996


begin 755 conf.ltr
M("`@("`@("`@("`@("`@("`@("`@(%-C:65N=&EF:6,M<')A8W1I8V%L(&-O
M;F9E<F5N8V4-"B`@("`@("`@(")42$]204-)0R!355)'15)9($%.1"!005)4
M24-53$%2(%%515-424].4R!/1B!/3D-/3$]'62`-"B`@+W-U<F=I8V%L('1R
M96%T;65N="!A;F0@:6UM=6YE+6-O<G)E8W1I;F<@=&AE<F%P>2!O9B!M86QI
M9VYA;G0@='5M;W5R<R\B(`T*#0H@("`@(%1H92!C;VYF97)E;F-E('=I;&P@
M8F4@:&5L9"!O;B!.;W9E;6)E<B`R-"TR-2P@,3DY-B!I;B!3="Y0971E<G-B
M=7)G#0IC:71Y(&AO<W!I=&%L($XR-B`O4G5S<VEA+"!3="Y0971E<G-B=7)G
M+"!+;W-T>75S:&MO('-T<F5E="P@,B\N#0H-"B`@("`@251%35,Z#0HM(&UO
M9&5R;B!P<F]B;&5M<R!O9B!T:&]R86-I8R!S=7)G97)Y("AS=7)G97)Y(&]F
M(&5S;W!H86=U<RP@;'5N9W,L#0H@('1R86-H96$@86YD(&)R;VYC:&DL(&UE
M9&EA<W1I;G5M+"!D:6%P:')A9VTI.R`-"BT at 9&EA9VYO<W1I8R!M971H;V1S
M(&EN(&UO9&5R;B!O;F-O;&]G>3L-"BT@<F%D:6-A;"!A;F0@<W5P97)R861I
M8V%L+"!S:6UU;'1A;F5O=7, at 86YD(&-O;6)I;F5D('-U<F=E<GD@:6X@#0H@
M(&UA;&EG;F%N8VEE<SL-"BT@;6]D97)N(&UE=&AO9',@;V8@:6UM=6YO=&AE
M<F%P>2!I;B!C86YC97(@86YD(&]T:&5R(&UA;&EG;F%N8VEE<RX@#0H-"B`@
M("`@5$A%($Q!3D=504=%(&]F('1H92!#;VYF97)E;F-E(&ES(%)U<W-I86X@
M8G5T('=E(&=A<F%N=&5E('-I;75L=&%N96]U<PT*:6YT97)P<F5T871I;VX@
M:6YT;R!%;F=L:7-H(&9O<B!F;W)E:6=N(&=U97-T<RX-"@T*("`@("!42$4@
M15A(24))5$E/3B!O9B!M;V1E<FX@;65D:6-A;"!E<75I<&UE;G0 at 86YD(&1R
M=6=S(&)E:6YG('!R;V1U8V5D(`T*8GD at 9F]R96EG;B!A;F0 at 9&]M97-T:6,@
M8V]M<&%N:65S(&ES('1O(&)E(&AE;&0N#0H-"B`@("`@06QL('1H92!M871E
M<FEA;', at 86-C97!T960@=&\@=&AE(&-O;F9E<F5N8V4@=VEL;"!B92!054),
M25-(140 at 8GD@#0II=', at 8F5G:6YN:6YG+B!792!W:6QL(&%C8V5P="!F;W(@
M<'5B;&EC871I;VX at 86QL('1H97-E<R!R96=A<F1I;F<@:71E;7,@#0IM96YT
M:6]N960 at 86)O=F4L(&)U="!N;R!M;W)E('1H86X@,B!P86=E<R!O9B!T>7!E
M9"!O<B!C;VUP=71E9"!T97AT#0HO,B!I;G1E<G9A;',O+"!I;B!%;F=L:7-H
M+B!4:&5S97,@<VAO=6QD(&)E('-E;G0@=&\@=&AE(&]R9V%N:7IO<G,@;V8@
M#0IT:&4 at 8V]N9F5R96YC92!U<"!T;R!/8W1O8F5R(#$L(#$Y.38N(%1H97-E
M<R!M87D at 8F4@92UM86EL960 at +W-E92!A9&1R97-S(`T*8F5L;W<O(&%S(&$@
M=&5X="!F:6QE("]-24-23U-/1E0 at 5T]21"!&3U(@5TE.1$]74R!F;W)M870@
M<')E9F5R86)L92\N#0H-"B`@("`@5$A%(%!!4E1)0TE0051)3TX at 1D5%(&UA
M:V5S('5P(#$P,"0 at +U531"\L(&%N9"!I="!W;W5L9"!B92!M;W)E(`T*8V]N
M=F5N:65N="!I9B!T:&4@<&%R=&EC:7!A;G1S('=O=6QD('!A>2!O;B!T:&5I
M<B!A<G)I=F%L(&1I<F5C=&QY('1O('1H90T*3W)G86YI>FEN9R!#;VUM971T
M964N(%!E<G-O;G,@=VEL;&EN9R!T;R!P87D@=&AR;W5G:"!B86YK(&%C8V]U
M;G1S(`T*87)E(&%D=FES960@=&\@92UM86EL(")396YD(&)A;FL@<F5Q=6ES
M:70B('1O('1H;W)A>$!I;F9O<')O+G-P8BYS=2P at 86YD(`T*86QL('1H92!D
M871A(&YE8V5S<V%R>2!W:6QL(&)E(&4M;6%I;&5D(&EN(')E='5R;BX@#0H-
M"B`@("`@4U1!64E.1R!I;B!3="Y0971E<G-B=7)G(&-I='D@:&]T96QS('=I
M;&P at 8F4@<')E<V5N=&5D('1O('1H92`-"G!A<G1I8VEP86YT<R!O9B!T:&4@
M0V]N9F5R96YC92!B>2!T:&5I<B!R97%U97-T<RX at 4&QE87-E(&EN9F]R;2!T
M:&4@#0I/<F=A;FEZ:6YG($-O;6UE='1E92!O9B!Y;W5R('!E<G-O;F%L('!A
M<G1I8VEP871I;VX@=&EL;"!/8W1O8F5R(#(P+"`Q.3DV+`T*<V\@=&AA="!W
M92!C;W5L9"!O<F1E<B!A(&AO=&5L(&9O<B!Y;W4@:6X@=&EM92X-"@T*("`@
M("!42$4 at 04=%3D1!(&]F('1H92!C;VYF97)E;F-E('=I;&P at 8F4@92UM86EL
M960@=&\@>6]U(&)Y('EO=7(@<F5Q=65S="`-"F%F=&5R($]C=&]B97(@,S`L
M(#$Y.38N#0H-"B`@("!0;&5A<V4 at 8V]N=&%C="!T:&4 at 3W)G86YI>FEN9R!C
M;VUM971E92!I;B!O;F4@;V8@=&AE(&9O;&QO=VEN9R!W87ES. at T*,2X at 4$]3
M5#H at +2!2=7-S:6$L(#$Y,S`Q-2!3="Y0971E<G-B=7)G+"!386QT>6MO=F$M
M4V-H961R:6YA('-T<BX at -#$L#0H@("`@("`@("`@($UE9&EC86P at 06-A9&5M
M>2!O9B!P;W-T9W)A9'5A=&4 at 961U8V%T:6]N+"!$97!A<G1M96YT(&]F(`T*
M("`@("`@("`@("!T:&]R86-I8R!S=7)G97)Y.PT*("`@("`@("`@+2!2=7-S
M:6$L(#$Y-C(T-R!3="Y0971E<G-B=7)G+"!+;W-T>75S:&MO('-T<BX@,BP@
M0VET>2!(;W-P:71A;"`-"B`@("`@("`@("`@3C(V+"!$97!A<G1M96YT(&]F
M('1H;W)A8V]A8F1O;6EN86P@<W5R9V5R>2X@#0H-"C(N(%!(3TY%.B`M("@X
M,3(I(#$R,RTS.2TS.2`O;V9F:6-E+RP@*#@Q,BD@,3`X+3,W+3 at X("]H;VUE
M+R`M(`T*("`@("`@("`@("`@5FEC=&]R($$N5&%R87-O=BP at 32Y$+BP at 0VAA
M:7)M86X@;V8@=&AE($]R9V%N:7II;F<@8V]M;65T964[#0H@("`@("`@("`@
M+2`H.#$R*2`Q,C,M,3$M.3, at +V]F9FEC92\L("@X,3(I(#$S-BTP."TR-"`O
M:&]M92\@+2!%=6=E;F4 at 4RX-"B`@("`@("`@("`@(%!O8F5G86QO=BX-"@T*
M,RX at 12U-04E,.B`@=&AO<F%X0&EN9F]P<F\N<W!B+G-U("`M($5U9V5N92!3
M+E!O8F5G86QO=@T*(`T*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M(%=I=&@@8F5S="!R96=A<F1S+`T*("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@(%9I8W1O<B!!+E1A<F%S;W8L($TN1"XL(`T*("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@($AE860@;V8@=&AE(&1E<&%R=&UE;G0@;V8@
M=&AO<F%C:6,@<W5R9V5R>2P-"B`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("!3="Y0971E<G-B=7)G($UE9&EC86P at 06-A9&5M>2!O9B`-"B`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("!P;W-T9W)A9'5A=&4 at 961U8V%T
#:6]N
`
end




More information about the Immuno mailing list